Dr. Lena Sharpe had processed hundreds of stool samples in her career, but never one that made her pause like this.
She reran it. Same result.
Then she noticed something else. The internal control spike-in (a synthetic DNA fragment added by Qiagen to track inhibition) was absent . That meant the sample hadn’t inhibited the PCR—it had overwhelmed it. The control was present but undetectable because the background DNA was so massive. qiagen stool kit
Instead, 99.7% of the reads matched a single, unclassified Proteobacteria sequence—one not in any public database. And the remaining 0.3%? Synthetic lambda phage DNA —the kind used as a positive control in Qiagen’s own manufacturing quality checks.
Lena wasn’t amused. She pulled up the donor metadata again. Donor K was part of a longitudinal study on diet and inflammation. His previous samples—collected three months ago—were normal: 120 ng/µl, typical Firmicutes-to-Bacteroidetes ratio. But this new sample? It looked like someone had poured a concentrated culture of E. coli directly into the Qiagen bead tube before shipping. Same result
She looked at the bead tube’s plastic cap. Qiagen’s kits are sterile, single-use, and sealed. But the barcode on this one—when she scanned it—showed it had been logged out of the freezer six months ago to “Donor K,” then returned unopened. Except it wasn’t unopened now. The foil seal inside the cap was wrinkled, as if someone had injected something through it with a fine needle.
“Maybe it’s a tumor,” he said, half-joking, squinting at the electropherogram. “Or maybe they’re eating pure bacterial lysate for breakfast.” That meant the sample hadn’t inhibited the PCR—it
Marcus stopped joking. “Lena… that’s not possible from a normal human stool. Even with severe bacterial overgrowth, you’d see host DNA diluting it.”